Form 8.3 - DECHRA PHARMACEUTICALS PLC Amend

Barclays PLC
18 December 2023
 

FORM 8.3 Amendment to Purchase

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short

 positions disclosed, if different from 1(a):

 

(c)

Name of offeror/offeree in relation to whose

 relevant securities this form relates:

DECHRA PHARMACEUTICALS PLC

(d)

If an exempt fund manager connected with an

 offeror/offeree, state this and specify identity of

 offeror/offeree:

 

(e)

Date position held/dealing undertaken:

07 Dec 2023

(f)

In addition to the company in 1(c) above, is the discloser making

 disclosures in respect of any other party to the offer?

NO

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 to which the disclosure relates following the dealing(if any)

Class of relevant security:

1p ordinary


Interests

Short Positions

Number

(%)

Number

(%)

(1) Relevant securities owned and/or controlled:

7,653,091

6.72%

957,692

0.84%

(2) Cash-settled derivatives:

953,254

0.84%

7,585,594

6.66%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 

0

0.00%

0

0.00%

 

 TOTAL:

 

8,606,345

7.56%

8,543,286

7.50%

(b)

Rights to subscribe for new securities (including directors and

 other executive options)

Class of relevant security in relation to

 which subscription right exists


Details, including nature of the rights

 concerned and relevant percentages:


3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchase and sales

Class of relevant

 security

Purchase/sale

Number of

 securities

Price per unit

1p ordinary

Purchase

21,658

38.3349  GBP

1p ordinary

Purchase

10,651

38.3281  GBP

1p ordinary

Purchase

7,241

38.3400  GBP

1p ordinary

Purchase

3,274

38.3380  GBP

1p ordinary

Purchase

2,240

38.3077  GBP

1p ordinary

Purchase

579

38.3200  GBP

1p ordinary

Purchase

338

38.3114  GBP

1p ordinary

Purchase

232

38.3387  GBP

1p ordinary

Purchase

74

38.3127  GBP

1p ordinary

Purchase

63

38.3136  GBP

1p ordinary

Sale

8,453

38.3203  GBP

1p ordinary

Sale

3,908

38.3400  GBP

1p ordinary

Sale

3,096

38.3361  GBP

1p ordinary

Sale

2,709

38.3070  GBP

1p ordinary

Sale

2,569

38.3093  GBP

1p ordinary

Sale

2,354

38.3224  GBP

1p ordinary

Sale

695

38.3029  GBP

1p ordinary

Sale

540

38.3200  GBP

(b)

Cash-settled derivative transactions

Class of

 relevant

 security

Product  description

Nature of dealing

Number of

 reference

 securities

Price per

 unit

1p ordinary

SWAP

Decreasing Long

2,830

38.3400  GBP

1p ordinary

SWAP

Decreasing Long

6,358

38.3479  GBP

1p ordinary

SWAP

Decreasing Long

6,485

38.3397  GBP

1p ordinary

SWAP

Decreasing Long

9,511

38.3232  GBP

1p ordinary

CFD

Decreasing Short

730

38.3171  GBP

1p ordinary

CFD

Decreasing Short

872

38.3148  GBP

1p ordinary

SWAP

Decreasing Short

2,342

38.2969  GBP

1p ordinary

SWAP

Decreasing Short

2,354

38.3224  GBP

1p ordinary

CFD

Decreasing Short

2,569

38.3093  GBP

1p ordinary

SWAP

Decreasing Short

3,096

38.3361  GBP

1p ordinary

SWAP

Increasing Long

8,453

38.3203  GBP

1p ordinary

SWAP

Increasing Short

222

38.3234  GBP

1p ordinary

CFD

Increasing Short

2,240

38.3076  GBP

1p ordinary

SWAP

Increasing Short

10,651

38.3281  GBP









(c)

Stock-settled derivative transactions

 (including options)

(i)

Writing, selling, purchasing or varying

Class

 of

 relevant

 security

Product

 description

Writing,

 purchasing,

 selling,

 varying etc

Number

 of

 securities

 to which

 option

 relates

Exercise

 price

 per unit

Type

Expiry

 date

Option

 money

 paid/

 received

 per unit

















(ii)

Exercising

 






Class of relevant

 security

Product description

Exercising/ exercised against

Number of

 securities

Exercise price per

 unit














(d)

Other dealings (including subscribing for

 new securities)

Class of relevant

 security

Nature of Dealings

Details

Price per unit (if

 applicable)





4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

 formal or informal, relating to relevant securities which may be an inducement to deal

 or refrain from dealing entered into by the person making the disclosure and any party

 to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or

 derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

 the person making the disclosure and any other person relating to:

 (i)  the voting rights of any relevant securities under any option; or

 (ii) the voting rights of future acquisition or disposal of any relevant securities to which

 any derivative is referenced:

NONE

(c)

Attachments

 






Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

18 Dec 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
Investor Meets Company
UK 100

Latest directors dealings